Aller au contenu principal
Accès ouvert déclaré 2025 review

Are we screening effectively? A systematic review and meta-analysis of proposed risk factors for rheumatoid arthritis-associated interstitial lung disease screening

3Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : no. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

OBJECTIVES: To systematically review and meta-analyse the risk factors proposed by the American College of Rheumatology and American College of Chest Physicians as screening tools for rheumatoid arthritis-associated interstitial lung disease (RA-ILD), focusing exclusively on studies using high-resolution computed tomography (HRCT) in prospectively collected data from unselected RA patients. METHOD: A comprehensive search was conducted to identify studies evaluating RA-ILD risk factors. Selection criteria included studies using HRCT in prospective, unselected RA cohorts. Data synthesis was performed to compute the prevalence of RA-ILD and evaluate the performance of dichotomous and continuous risk factors. RESULTS: In the analysis of nine studies involving 1380 RA patients, RA-ILD was identified in 18.9% via HRCT, with prevalence rates ranging from 6.7% to 42.7%. No studies were found that examined the risk factors collectively. Male sex and history of smoking were, respectively, 12.6% and 12.2% higher in RA-ILD patients compared to those without ILD. Average age at RA disease onset was 7.0 years higher in RA-ILD patients than in the non-ILD group. Disease Activity Scores in 28 joints (DAS28) were similar between the two groups. However, limited data were available for high-titre seropositivity and body mass index. CONCLUSIONS: The proposed risk factors for RA-ILD screening lack robust evidence, and existing data indicate insufficient individual predictive power. Physicians are advised to continue screening for RA-ILD using comprehensive clinical judgement rather than relying solely on these risk factors. Further research is necessary to develop robust screening tools to improve early detection of RA-ILD.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Are we screening effectively? A systematic review and meta-analysis of proposed risk factors for rheumatoid arthritis-associated interstitial lung disease screening
Date Crossref
09/09/2025
Éditeur
Informa UK Limited
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisRheumatoid Arthritis Research and TherapiesSarcoidosis and Beryllium Toxicity Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.